"Internal and Family Medicine Suite 2000: 708-915-3100 Endocrinology and Nephrology Suite 3000: 708-915-3100 Neurology Suite 2650: 773-702-6222 Obstetrics and Gynecology Suite 3800: 773-702-1465 Orthopaedics Suite 1400: 708-647-7565 Otolaryngology (ENT) Suite 2200: 708-798-0200 Pediatrics Suite 2500 (Child Life Center): 708-799-7600 Our 24-hour walk-in urgent care center addresses the need for fast, efficient, quality lower-level emerge"

During the past decade, UChicago Medicine at Ingalls - Flossmoor conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UChicago Medicine at Ingalls - Flossmoor" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "UChicago Medicine at Ingalls - Flossmoor" are "Multiple Myeloma" (2 trials) and "Neoplasms" (1 trials). Many other conditions were trialed in "UChicago Medicine at Ingalls - Flossmoor" in a lesser frequency.

Most popular intervention types in "UChicago Medicine at Ingalls - Flossmoor" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "5-FU" (1 trials), "Bevacizumab" (1 trials), "Capecitabine" (1 trials), "Cetuximab" (1 trials) and "Elranatamab + Nirogacestat" (1 trials). Other intervention names were less common.

The vast majority of trials in "UChicago Medicine at Ingalls - Flossmoor" are 3 trials for "All" genders.

Currently, there are NaN active trials in "UChicago Medicine at Ingalls - Flossmoor". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in UChicago Medicine at Ingalls - Flossmoor, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UChicago Medicine at Ingalls - Flossmoor, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".